Meningococcal disease epidemiology – United States, 2020–2023

Amy B Rubis, Basanta R Wagle, Shreya Khuntia, Carolyn I Wiest, Sandip Shrestha, Vishakh Walia, Rebecca L Howie, Sara L Eisen · 2026

Read Meningococcal disease epidemiology – United States, 2020–2023 by Amy B Rubis, Basanta R Wagle, Shreya Khuntia, Carolyn I Wiest, Sandip Shrestha, Vishakh Walia, Rebecca L Howie, Sara L Eisen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0356184.txt.

Description

Amy B Rubis and colleagues summarize United States surveillance for meningococcal disease across the first four years of the twenty twenties. The illness is rare but swift and deadly, so health officials track every case and fingerprint the bacteria by genome. Reports gathered through national systems covered well over a thousand confirmed and probable cases, with detailed strain typing.

Case rates bottomed during the pandemic's second year and rose to their highest in the final year studied. One bacterial group, type Y, climbed from a small share to more than half of cases, and within it a strain family once rare in the country came to dominate. Nine outbreaks began in the period, some years accounting for a large share of all cases. Rubis and colleagues say shifting strains must guide vaccine and response planning.

Catalog record

CREATORAmy B Rubis, Basanta R Wagle, Shreya Khuntia, Carolyn I Wiest, Sandip Shrestha, Vishakh Walia, Rebecca L Howie, Sara L Eisen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37333
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0356184

Browse the full library · About the Tower of Babel